Modified anal fistula plug with drainage seton shows early recovery benefits and comparable 12-month outcomes to conventional treatment in cryptoglandular anal fistula.
This prospective cohort study included 140 patients with cryptoglandular anal fistula at a single center in West China Hospital. Participants were treated either with a modified anal fistula plug combined with a drainage seton or with conventional treatment. The primary outcome assessed was the 12-month healing rate, while secondary outcomes included postoperative pain, healing time, recurrence, functional recovery, costs, and hospital stay duration.
The modified anal fistula plug group demonstrated lower early postoperative pain and a shorter median time to healing compared to the conventional treatment group. Early functional recovery was also higher in the intervention group. In a subgroup analysis, patients with a preoperative disease duration of approximately 45 to 365 days showed greater acceleration in healing with the modified plug.
At 12 months, overall clinical effectiveness and recurrence rates did not differ significantly between the modified anal fistula plug group and the conventional treatment group. The study did not report specific adverse events, serious adverse events, discontinuations, or detailed tolerability data. Funding sources and potential conflicts of interest were not reported.
The findings suggest that the modified anal fistula plug combined with a drainage seton facilitates early recovery and may reduce costs and hospital stay. It supports the use of this technique as a sphincter-preserving, cost-conscious alternative for cryptoglandular anal fistula, though long-term superiority over conventional treatment remains unproven in this cohort.